BATS BZX Real-Time Price
As of 2:16pm ET
| +1.34 / +1.15%|
The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 129.50, with a high estimate of 150.00 and a low estimate of 85.00. The median estimate represents a +9.81% increase from the last price of 117.93.
The current consensus among 27 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.